[8-K] Neurogene, Inc. Reports Material Event
On August 11, 2025, Neurogene Inc. reported that it issued a press release announcing financial results for the quarter ended June 30, 2025 and posted an updated corporate presentation on its website. The Form 8-K attaches Exhibit 99.1 (press release) and Exhibit 99.2 (corporate presentation) and states these exhibits are being furnished, not filed, so they are not subject to Section 18 liabilities or deemed incorporated by reference. The filing text does not include the actual earnings figures; the report is signed by Christine Mikail, President and Chief Financial Officer.
Il 11 agosto 2025 Neurogene Inc. ha comunicato di aver pubblicato un comunicato stampa sui risultati finanziari del trimestre chiuso il 30 giugno 2025 e di aver caricato sul proprio sito una presentazione aziendale aggiornata. Il modulo 8鈥慘 allega l'Exhibit 99.1 (comunicato stampa) e l'Exhibit 99.2 (presentazione aziendale) e specifica che tali allegati sono forniti, non depositati, pertanto non sono soggetti alle responsabilit脿 previste dalla Sezione 18 n茅 si intendono incorporati per riferimento. Nel testo del documento non sono riportati i dati effettivi sugli utili; il rapporto 猫 firmato da Christine Mikail, Presidente e Direttrice finanziaria.
El 11 de agosto de 2025, Neurogene Inc. inform贸 que emiti贸 un comunicado de prensa con los resultados financieros del trimestre cerrado el 30 de junio de 2025 y que public贸 en su sitio web una presentaci贸n corporativa actualizada. El formulario 8鈥慘 adjunta el Anexo 99.1 (comunicado de prensa) y el Anexo 99.2 (presentaci贸n corporativa) y se帽ala que estos anexos se est谩n proporcionando, no presentando, por lo que no est谩n sujetos a las responsabilidades de la Secci贸n 18 ni se consideran incorporados por referencia. El texto del informe no incluye las cifras reales de ganancias; el informe est谩 firmado por Christine Mikail, presidenta y directora financiera.
2025雲� 8鞗� 11鞚�, Neurogene Inc.電� 2025雲� 6鞗� 30鞚茧 膦呺霅� 攵勱赴鞚� 鞛 鞁れ爜鞚� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚绊彫頃橁碃 鞛愳偓 鞗轨偓鞚错姼鞐� 鞐呺嵃鞚错姼霅� 旮办梾 頂勲爤鞝犿厡鞚挫厴鞚� 瓴岇嫓頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. Form 8鈥慘鞐愲姅 Exhibit 99.1(氤措弰鞛愲) 氚� Exhibit 99.2(旮办梾 頂勲爤鞝犿厡鞚挫厴)臧� 觳秬霅橃柎 鞛堨溂氅�, 鞚措摛 鞛愲電� 鞝滌稖霅� 瓴冹澊 鞎勲媹霛� 鞝滉车霅� 瓴�(furnished, not filed)鞙茧 氇呾嫓霅橃柎 鞛堨柎 靹轨厴 18鞚� 毂呾瀯 雽�靸侅澊 霅橃 鞎婌溂氅� 彀胳“鞐� 鞚橅暅 韼胳瀰鞙茧 臧勳＜霅橃 鞎婌姷雼堧嫟. 鞝滌稖 氍胳劀鞐愲姅 鞁れ牅 鞁れ爜 靾橃箻電� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 氤搓碃靹滊姅 靷灔 瓴� 斓滉碃鞛毂呾瀯鞛�(CFO)鞚� Christine Mikail鞚� 靹滊獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le 11 ao没t 2025, Neurogene Inc. a annonc茅 avoir publi茅 un communiqu茅 de presse pr茅sentant les r茅sultats financiers du trimestre clos le 30 juin 2025 et avoir mis en ligne une pr茅sentation d'entreprise mise 脿 jour. Le formulaire 8鈥慘 joint l'Exhibit 99.1 (communiqu茅 de presse) et l'Exhibit 99.2 (pr茅sentation d'entreprise) et pr茅cise que ces pi猫ces sont fournies, non d茅pos茅es, de sorte qu'elles ne sont pas soumises aux responsabilit茅s pr茅vues par la Section 18 et ne sont pas r茅put茅es incorpor茅es par renvoi. Le texte du d茅p么t n'inclut pas les chiffres r茅els des r茅sultats ; le rapport est sign茅 par Christine Mikail, pr茅sidente et directrice financi猫re.
Am 11. August 2025 teilte Neurogene Inc. mit, dass das Unternehmen eine Pressemitteilung mit den Finanzergebnissen f眉r das zum 30. Juni 2025 abgeschlossene Quartal herausgegeben und eine aktualisierte Unternehmenspr盲sentation auf seiner Website ver枚ffentlicht hat. Das Form 8鈥慘 f眉gt Anlage 99.1 (Pressemitteilung) und Anlage 99.2 (Unternehmenspr盲sentation) bei und weist darauf hin, dass diese Anlagen bereitgestellt, nicht eingereicht wurden, sodass sie nicht den Haftungsbestimmungen von Section 18 unterliegen und nicht durch Verweis eingegliedert werden. Der Eintrag enth盲lt keine tats盲chlichen Gewinnzahlen; der Bericht ist von Christine Mikail, Pr盲sidentin und Chief Financial Officer, unterzeichnet.
- Issued a press release announcing quarterly results for the quarter ended June 30, 2025
- Posted an updated corporate presentation and attached both documents as Exhibits 99.1 and 99.2
- None.
Insights
TL;DR: Neurogene furnished its Q2 2025 results press release and an updated presentation; the 8-K itself contains no financial figures, so direct investor implications are limited.
The filing notifies investors that the company announced quarterly results and uploaded a corporate presentation, but it does not embed the earnings metrics in the 8-K text. For market impact, the attached press release and presentation (Exhibits 99.1 and 99.2) contain the material details investors will need to assess performance. The 8-K functions mainly as formal notice of those disclosures; absent the exhibits' content here, the filing is procedural rather than informative about results.
TL;DR: Exhibits are explicitly "furnished, not filed," which limits legal incorporation and Section 18 liability; the report follows routine disclosure practice.
The 8-K clearly states Exhibits 99.1 and 99.2 are furnished and therefore are not subject to Section 18 liability or automatically incorporated into other Exchange Act or Securities Act filings. That designation is important for legal posture and limits statutory liability for the content of those exhibits within this filing. The report is signed by the company CFO, reflecting standard internal authorization for such disclosures.
Il 11 agosto 2025 Neurogene Inc. ha comunicato di aver pubblicato un comunicato stampa sui risultati finanziari del trimestre chiuso il 30 giugno 2025 e di aver caricato sul proprio sito una presentazione aziendale aggiornata. Il modulo 8鈥慘 allega l'Exhibit 99.1 (comunicato stampa) e l'Exhibit 99.2 (presentazione aziendale) e specifica che tali allegati sono forniti, non depositati, pertanto non sono soggetti alle responsabilit脿 previste dalla Sezione 18 n茅 si intendono incorporati per riferimento. Nel testo del documento non sono riportati i dati effettivi sugli utili; il rapporto 猫 firmato da Christine Mikail, Presidente e Direttrice finanziaria.
El 11 de agosto de 2025, Neurogene Inc. inform贸 que emiti贸 un comunicado de prensa con los resultados financieros del trimestre cerrado el 30 de junio de 2025 y que public贸 en su sitio web una presentaci贸n corporativa actualizada. El formulario 8鈥慘 adjunta el Anexo 99.1 (comunicado de prensa) y el Anexo 99.2 (presentaci贸n corporativa) y se帽ala que estos anexos se est谩n proporcionando, no presentando, por lo que no est谩n sujetos a las responsabilidades de la Secci贸n 18 ni se consideran incorporados por referencia. El texto del informe no incluye las cifras reales de ganancias; el informe est谩 firmado por Christine Mikail, presidenta y directora financiera.
2025雲� 8鞗� 11鞚�, Neurogene Inc.電� 2025雲� 6鞗� 30鞚茧 膦呺霅� 攵勱赴鞚� 鞛 鞁れ爜鞚� 氚滍憸頃橂姅 氤措弰鞛愲毳� 氚绊彫頃橁碃 鞛愳偓 鞗轨偓鞚错姼鞐� 鞐呺嵃鞚错姼霅� 旮办梾 頂勲爤鞝犿厡鞚挫厴鞚� 瓴岇嫓頄堧嫟瓿� 氤搓碃頄堨姷雼堧嫟. Form 8鈥慘鞐愲姅 Exhibit 99.1(氤措弰鞛愲) 氚� Exhibit 99.2(旮办梾 頂勲爤鞝犿厡鞚挫厴)臧� 觳秬霅橃柎 鞛堨溂氅�, 鞚措摛 鞛愲電� 鞝滌稖霅� 瓴冹澊 鞎勲媹霛� 鞝滉车霅� 瓴�(furnished, not filed)鞙茧 氇呾嫓霅橃柎 鞛堨柎 靹轨厴 18鞚� 毂呾瀯 雽�靸侅澊 霅橃 鞎婌溂氅� 彀胳“鞐� 鞚橅暅 韼胳瀰鞙茧 臧勳＜霅橃 鞎婌姷雼堧嫟. 鞝滌稖 氍胳劀鞐愲姅 鞁れ牅 鞁れ爜 靾橃箻電� 韽暔霅橃柎 鞛堨 鞎婌溂氅�, 氤搓碃靹滊姅 靷灔 瓴� 斓滉碃鞛毂呾瀯鞛�(CFO)鞚� Christine Mikail鞚� 靹滊獏鞚� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Le 11 ao没t 2025, Neurogene Inc. a annonc茅 avoir publi茅 un communiqu茅 de presse pr茅sentant les r茅sultats financiers du trimestre clos le 30 juin 2025 et avoir mis en ligne une pr茅sentation d'entreprise mise 脿 jour. Le formulaire 8鈥慘 joint l'Exhibit 99.1 (communiqu茅 de presse) et l'Exhibit 99.2 (pr茅sentation d'entreprise) et pr茅cise que ces pi猫ces sont fournies, non d茅pos茅es, de sorte qu'elles ne sont pas soumises aux responsabilit茅s pr茅vues par la Section 18 et ne sont pas r茅put茅es incorpor茅es par renvoi. Le texte du d茅p么t n'inclut pas les chiffres r茅els des r茅sultats ; le rapport est sign茅 par Christine Mikail, pr茅sidente et directrice financi猫re.
Am 11. August 2025 teilte Neurogene Inc. mit, dass das Unternehmen eine Pressemitteilung mit den Finanzergebnissen f眉r das zum 30. Juni 2025 abgeschlossene Quartal herausgegeben und eine aktualisierte Unternehmenspr盲sentation auf seiner Website ver枚ffentlicht hat. Das Form 8鈥慘 f眉gt Anlage 99.1 (Pressemitteilung) und Anlage 99.2 (Unternehmenspr盲sentation) bei und weist darauf hin, dass diese Anlagen bereitgestellt, nicht eingereicht wurden, sodass sie nicht den Haftungsbestimmungen von Section 18 unterliegen und nicht durch Verweis eingegliedert werden. Der Eintrag enth盲lt keine tats盲chlichen Gewinnzahlen; der Bericht ist von Christine Mikail, Pr盲sidentin und Chief Financial Officer, unterzeichnet.
FAQ
What did Neurogene (NGNE) disclose in this Form 8-K?
Does the 8-K include the actual Q2 2025 financial figures?
Where can I find the press release and presentation referenced in the 8-K?
Are the attached exhibits considered "filed" under the Exchange Act?
Who signed the Form 8-K for Neurogene?
